Synergy Pharmaceuticals Inc. (SGYP) Forms $1.93 Double Bottom; 1st Source (SRCE) Shorts Increased By 0.66%

1st Source Corporation (NASDAQ:SRCE) had an increase of 0.66% in short interest. SRCE’s SI was 229,600 shares in March as released by FINRA. Its up 0.66% from 228,100 shares previously. With 55,200 avg volume, 4 days are for 1st Source Corporation (NASDAQ:SRCE)’s short sellers to cover SRCE’s short positions. The SI to 1st Source Corporation’s float is 2.9%. The stock decreased 1.03% or $0.55 during the last trading session, reaching $52.74. About 39,896 shares traded. 1st Source Corporation (NASDAQ:SRCE) has risen 36.45% since March 21, 2017 and is uptrending. It has outperformed by 19.75% the S&P500.

Synergy Pharmaceuticals Inc. (SGYP) formed double bottom with $1.79 target or 7.00% below today’s $1.93 share price. Synergy Pharmaceuticals Inc. (SGYP) has $476.05 million valuation. It closed at $1.93 lastly. It is down 24.44% since March 21, 2017 and is uptrending. It has outperformed by 7.74% the S&P500.

Analysts await Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) to report earnings on May, 9. They expect $-0.16 earnings per share, up 46.67% or $0.14 from last year’s $-0.3 per share. After $-0.18 actual earnings per share reported by Synergy Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts -11.11% EPS growth.

Investors sentiment decreased to 1.22 in Q3 2017. Its down 0.68, from 1.9 in 2017Q2. It fall, as 16 investors sold Synergy Pharmaceuticals Inc. shares while 23 reduced holdings. 21 funds opened positions while 53 raised stakes. 147.06 million shares or 7.33% less from 158.68 million shares in 2017Q2 were reported. New Jersey-based Palisade Capital Mngmt Limited Co Nj has invested 0.01% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Grp One Trading Lp owns 1.11M shares for 0.03% of their portfolio. Jpmorgan Chase Co has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Guggenheim Cap Ltd Liability Corporation reported 75,701 shares. Hightower accumulated 0.02% or 845,264 shares. Ameritas Inv Prns Inc invested in 0% or 19,906 shares. Barclays Public Ltd Liability Com stated it has 0% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Prelude Cap Management Ltd Liability Corp accumulated 139,704 shares. Swiss National Bank reported 0% stake. D E Shaw & Comm reported 35,349 shares stake. Kingdon Cap Management Limited Company holds 0.15% or 769,140 shares. The Missouri-based Benjamin F Edwards Co has invested 0% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Ingalls And Snyder Ltd Limited Liability Company reported 0% stake. Parallax Volatility Advisers Limited Partnership holds 34,054 shares or 0% of its portfolio. Bruce & Com holds 100,000 shares or 0.06% of its portfolio.

Among 8 analysts covering Synergy Pharmaceuticals (NASDAQ:SGYP), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 75% are positive. Synergy Pharmaceuticals had 42 analyst reports since August 25, 2015 according to SRatingsIntel. BTIG Research initiated it with “Buy” rating and $11 target in Tuesday, August 25 report. On Thursday, October 29 the stock rating was reinitiated by TH Capital with “Buy”. On Tuesday, August 1 the stock rating was maintained by BTIG Research with “Buy”. The stock of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) earned “Buy” rating by BTIG Research on Friday, January 26. The stock has “Buy” rating by Oppenheimer on Tuesday, October 10. The stock of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has “Buy” rating given on Thursday, August 10 by Oppenheimer. The firm has “Buy” rating given on Thursday, November 9 by Cantor Fitzgerald. The stock of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) earned “Sell” rating by Citigroup on Thursday, April 6. Oppenheimer downgraded Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) on Friday, January 5 to “Perform” rating. The company was maintained on Wednesday, September 13 by Citigroup.

Investors sentiment decreased to 0.8 in Q3 2017. Its down 0.33, from 1.13 in 2017Q2. It turned negative, as 4 investors sold 1st Source Corporation shares while 35 reduced holdings. 11 funds opened positions while 33 raised stakes. 18.16 million shares or 0.27% more from 18.11 million shares in 2017Q2 were reported. 19,947 were reported by Guggenheim Cap Ltd Liability. Prescott Group Inc Mngmt Lc stated it has 21,222 shares. First Trust Advisors Ltd Partnership has 0.01% invested in 1st Source Corporation (NASDAQ:SRCE) for 56,922 shares. 1St Source State Bank invested in 7.36M shares. Moreover, Bartlett And Company Llc has 0.01% invested in 1st Source Corporation (NASDAQ:SRCE). Tiaa Cref Invest Management Limited Liability Company, a New York-based fund reported 42,616 shares. Fmr Ltd Liability Company stated it has 0% in 1st Source Corporation (NASDAQ:SRCE). Counselors invested in 18,285 shares. Wells Fargo Co Mn invested 0% of its portfolio in 1st Source Corporation (NASDAQ:SRCE). Ubs Asset Management Americas has invested 0% in 1st Source Corporation (NASDAQ:SRCE). Reinhart invested 0.42% in 1st Source Corporation (NASDAQ:SRCE). Blackrock has 1.11 million shares for 0% of their portfolio. Metropolitan Life Insur owns 11,024 shares. Indiana Investment Management Co holds 1.39% or 56,832 shares. Strs Ohio holds 0% in 1st Source Corporation (NASDAQ:SRCE) or 16,400 shares.

Among 3 analysts covering 1st Source (NASDAQ:SRCE), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. 1st Source had 11 analyst reports since July 21, 2016 according to SRatingsIntel. The rating was maintained by Keefe Bruyette & Woods on Thursday, June 1 with “Hold”. Keefe Bruyette & Woods maintained the shares of SRCE in report on Tuesday, October 3 with “Hold” rating. The firm earned “Hold” rating on Thursday, December 21 by Keefe Bruyette & Woods. Keefe Bruyette & Woods maintained it with “Hold” rating and $50.0 target in Friday, October 20 report. The stock of 1st Source Corporation (NASDAQ:SRCE) has “Overweight” rating given on Thursday, January 12 by Piper Jaffray. The firm earned “Neutral” rating on Thursday, July 21 by DA Davidson. The stock has “Buy” rating by Piper Jaffray on Thursday, July 20. As per Friday, July 21, the company rating was maintained by Keefe Bruyette & Woods. Piper Jaffray maintained the shares of SRCE in report on Friday, October 6 with “Buy” rating. On Monday, October 23 the stock rating was maintained by Piper Jaffray with “Buy”.

1st Source Corporation operates as the bank holding firm for 1st Source Bank that provides commercial and consumer banking services, trust and investment management services, and insurance to individual and business clients. The company has market cap of $1.42 billion. The Company’s consumer banking services include checking and savings accounts; certificates of deposit; individual retirement accounts; on-line and mobile banking products; automated teller machine services; consumer loans, real estate loans, and lines of credit; and financial planning, financial literacy, and other consultative services. It has a 20.28 P/E ratio. The firm also offers commercial, small business, agricultural, and real estate loans for general corporate purposes, including financing for industrial and commercial properties, equipment, inventories, accounts receivables, and acquisition financing; and commercial leasing, treasury management, and retirement planning services.

Since March 9, 2018, it had 0 insider purchases, and 1 sale for $443,750 activity. Egidi Allison N sold $443,750 worth of stock or 8,500 shares.